These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17 related articles for article (PubMed ID: 6957250)
1. Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside. Dhaliwal HS; Shannon MS; Barnett MJ; Prentice HG; Bragman K; Malpas JS; Lister TA Cancer Chemother Pharmacol; 1986; 18(1):59-62. PubMed ID: 3463435 [TBL] [Abstract][Full Text] [Related]
2. 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia. Legha SS; Keating MJ; Zander AR; McCredie KB; Bodey GP; Freireich EJ Ann Intern Med; 1980 Jul; 93(1):17-21. PubMed ID: 6930826 [TBL] [Abstract][Full Text] [Related]
3. 4'-(9-acridinylamino)methane-sulfon-m-anisidide (m-AMSA) and 5-azacytidine (AZA) in the treatment of relapsed adult acute leukemia. Kahn SB; Sklaroff R; Lebedda J; Conroy JF; Bulova S; Brodsky I Am J Clin Oncol; 1983 Aug; 6(4):493-502. PubMed ID: 6191561 [TBL] [Abstract][Full Text] [Related]
4. [Case of refractory acute myeloblastic leukemia who achieved complete remission by a new anti-leukemic agent, 4'-(9-acridinylamino) methanesulfon-m-anisidide (AMSA)]. Nagura E; Kawashima K; Suzuki H; Ohno R; Yamada K; Yokomaku S; Ogawa M Rinsho Ketsueki; 1983 May; 24(5):632-8. PubMed ID: 6577212 [No Abstract] [Full Text] [Related]
5. Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA). Fanucchi MP; Arlin ZA Cancer Chemother Pharmacol; 1982 Dec; 10(1):27-8. PubMed ID: 6961970 [TBL] [Abstract][Full Text] [Related]
6. Acridinyl anisidide (m-AMSA) therapy in 11 patients with refractory acute leukemia. Naparstek E; Shinar E; Polliack A Isr J Med Sci; 1984 Feb; 20(2):118-22. PubMed ID: 6546740 [TBL] [Abstract][Full Text] [Related]